A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Pfizer
Pfizer
Fate Therapeutics
Novartis
Pfizer
Enliven Therapeutics
Toray Industries, Inc
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Eli Lilly and Company
National University Hospital, Singapore
AbbVie
Canadian Cancer Trials Group
Gilead Sciences
Rutgers, The State University of New Jersey